News & Media
-
Biopharmaceutical Manufacturing from Clinical to Commercial StageTopic : Biopharmaceutical Manufacturing from Clinical to Commercial Stage by Single Use System- Event : 11th Biologics Manufacturing Korea- Conference : Enhancing Korea's Vein-to-Vein Supply Chain Management with the Right Technology, Governance and Strategies - Presentation Date : June 29, 2022- Venue : Songdo Convensia, Incheon, Korea
-
Prestige Biologics Corporate Video 2022 (English)
-
Prestige Biologics wins Best CDMO Award at the Korea Bioprocessing Excellence Awards 2022Prestige Biologics (CEO Yang Jae-young), specializing in biopharmaceutical CDMO, has won the Best CDMO Award at the Korea Bioprocessing Excellence Awards 2022, which was held on June 29 at the Songdo Convention Center in Incheon, South Korea.The Korea Bioprocessing Excellence Awards, held by IMPAC, aims to recognize organizations within Korea that have engaged in substantial efforts to innovate, optimize processes, and uphold a high level of efficacy, quality, and safety in biological products manufacturing. With high reputation on its biomanufacturing facilities and technologies, Prestige Biologics has been recognized as the winner of the Best CDMO Award this year for contributing to reducing cost, improving speed, and enhancing quality in bioprocessing.
-
BIO International Convention 2022
-
IPO Press Center 2021.02.19
-
Prestige Biologics Introduction Video